Helus Pharma Appoints Michael Cola as New CEO to Steer Company’s Growth
Helus: Helus PharmaTM (‘Helus’) (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company focused on developing novel serotonergic agonists, has announced the appointment of Michael Cola as Chief Executive Officer, effective immediately….